CD8A and neoplasm: On the other hand, we have shown that PTP1B levels are elevated in intratumoral CD8+ effector T cells isolated from human melanomas or syngeneic tumors in mice, and that the inhibition or deletion of PTP1B in T cells, or CAR T cells can markedly enhance anti-tumor immunity by promoting STAT-5 signaling11.